2026-525790-39-00招募中1 期
A study to investigate the repeat-dose pharmacokinetics of a combined oral contraceptive when given alone and in combination with ganfeborole in female participants of non-childbearing potential.
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 28
- 试验地点
- 2
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
EU GSK Clinical Trials Call Center
Scientific
Glaxosmithkline Research & Development Limited
研究点 (2)
Loading locations...
相似试验
已完成
1 期
Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of L03TD1 in Healthy VolunteersType 2 Diabetes Mellitus (T2DM)NCT07533539Celltrion48
招募中
1 期
To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Hepatic Impairment SubjectsMyelofibrosisNCT07480824Chia Tai Tianqing Pharmaceutical Group Co., Ltd.24
招募中
1 期
Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Subcutaneous Injections of NNC0582-0001 in Healthy Adults2023-506928-83-00Novo Nordisk A/S56
招募中
1 期
A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Volunteers and Multiple Doses in Participants With Moderate to Severe Atopic DermatitisNCT07604324Novartis Pharmaceuticals63
招募中
1 期
A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 TabletsObesity & OverweightNCT07652047Corxel Pharmaceuticals90